Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Nasopharyngeal Carcinoma 23Squamous Cell Carcinoma of Head and Neck 14Nasopharyngeal Neoplasms 3Mouth Neoplasms 2Hypopharyngeal Neoplasms 2Head and Neck Neoplasms 2Thyroid Neoplasms 1Salivary Gland Neoplasms 1Neoplasm Metastasis 1Laryngeal Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Cisplatin 29Magnetic Resonance Spectroscopy 16Specimen Handling 13Radiotherapy 12pembrolizumab 11Radiotherapy, Intensity-Modulated 11Cetuximab 11Surgical Procedures, Operative 9Paclitaxel 9Fluorouracil 9Docetaxel 9Platinum 81,2-diaminocyclohexaneplatinum II citrate 8Radiation 6Carboplatin 6Taxes 5Biopsy 5toripalimab 4X-Rays 4Surveys and Questionnaires 4Fluorodeoxyglucose F18 4Chemoradiotherapy 4Celecoxib 4(225)Ac-DOTA-c(RGDyK) 4Immunohistochemistry 3Counseling 3130-nm albumin-bound paclitaxel 3motexafin gadolinium 2ipatasertib 2camrelizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hypopharyngeal Neoplasms × camrelizumab × Head & Neck × Clear all
NCT04156698 2023-08-09

Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma

Eye & ENT Hospital of Fudan University

Phase 2 Unknown
51 enrolled
Head & Neck

Hypopharyngeal Neoplasms

NCT04539600 2021-08-19

Induction Chemotherapy Combined With Camrelizumab in Locoregionally Advanced Hypopharyngeal Cancer

Sun Yat-sen University

Phase 2 Unknown
23 enrolled
Head & Neck

Hypopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡